NCT04578158View on ClinicalTrials.gov

Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

September 29, 2020

Primary Completion Date

March 28, 2021

Study Completion Date

April 15, 2021

Conditions
COVID-19
Interventions
DRUG

Standard COVID-19 care

Patients will receive standard covid-19 care as per the hospital/physician guidelines

DIETARY_SUPPLEMENT

Quercetin Phytosome

Patients will receive a daily dose of 400 mg of oral Quercetin Phytosome

Trial Locations (1)

76090

Liaquat University Hospital, Jāmshoro

All Listed Sponsors
lead

Liaquat University of Medical & Health Sciences

OTHER

NCT04578158 - Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19 | Biotech Hunter | Biotech Hunter